Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer. [electronic resource]
Producer: 20160224Description: 1252-60 p. digitalISSN:- 1542-6270
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Disease-Free Survival
- Estradiol -- analogs & derivatives
- Female
- Fulvestrant
- Humans
- Letrozole
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- administration & dosage
- Piperazines -- therapeutic use
- Pyridines -- therapeutic use
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- metabolism
- Triazoles -- administration & dosage
- United States
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.